Griseofulvin Tablet 500mg GMP Certificated Pharmaceutical Drugs

China Griseofulvin Tablet 500mg GMP Certificated Pharmaceutical Drugs, Find details about China Fulvicin, Grisefulvin Grivulfin from Griseofulvin Tablet 500mg GMP Certificated Pharmaceutical Drugs

Pharmaceutical Technology
Chemical Synthesis
Standard
B.P./USP
Packaging
10*2 ; 10*10 ; 20*1
Storage
Cool and Dry Place
Trademark
OEM
Specification
Griseofulvin 500mg
Origin
China
Pharmaceutical Technology
Chemical Synthesis
Standard
B.P./USP
Packaging
10*2 ; 10*10 ; 20*1
Storage
Cool and Dry Place
Trademark
OEM
Specification
Griseofulvin 500mg
Origin
China
Product name: Griseofulvin Tablet
Category: Tablets
Package: 500mg*10tabs*2blisters/box,
                 500mg*20tabs/blisters/box
                 500mg*10tabs*10blisters/box,

Brand: OEM/GMP 
Packaging Details: As usual, we also can make as your requirement. 

Indications: 
Griseofulvin is primarily indicated in conditions like Dermatophytic infections, Fungal infection, Parkinson's disease. 
This drug is contraindicated in patients with porphyria, hepatocellular failure, and in individuals with a history of hypersensitivity to griseofulvin.
Adverse reactions of griseofulvin are uncommon. Nausea, diarrhea, headache, skin eruptions and photosensitivity are occasionally observed. Hepatotoxicity and neurological side effects may rarely occur.
Drug Interactions:
Griseofulvin can interact with blood thinners and birth control pills.
Precautions & Warning:
Caution should be exercised in patients with history of liver disease, porphyria, lupus, or history of alcohol abuse, any allergy, who are taking other medications, during pregnancy and breastfeeding.
Avoid exposure to sunlight.
Use in Pregnancy and Nursing Mothers:
Griseofulvin is assigned to pregnancy category C. Animal studies have revealed evidence of embryotoxicity and teratogenicity. There are no controlled data in human pregnancies; however, there are reports of congenital anomalies, including cases of conjoined twins in two women, as well as increased risk of spontaneous abortion. The manufacturer considers griseofulvin use to be contraindicated during pregnancy. There are no data on the excretion of griseofulvin into human milk.
Treatment/antidote in The Event of Overdose:
Treatment is symptomatic and supportive. There is no specific antidote for treatment of griseofulvin intoxication.
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.
Griseofulvin Tablet 500mg GMP Certificated Pharmaceutical Drugs